-
Catalyst Pharmaceuticals' (CPRX) "Overweight" Rating Reaffirmed at Stephens
来源: Buzz FX / 28 2月 2025 09:06:15 America/Chicago
Catalyst Pharmaceuticals' (CPRX) "Overweight" Rating Reaffirmed at Stephens Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Catalyst Pharmaceuticals ( NASDAQ:CPRX - Get Free Report ) 's stock had its "overweight" rat
Read more...